A systematic review and meta-analysis of clinical trials implementing aromatase inhibitors to treat male infertility.


Journal

Asian journal of andrology
ISSN: 1745-7262
Titre abrégé: Asian J Androl
Pays: China
ID NLM: 100942132

Informations de publication

Date de publication:
Historique:
pubmed: 18 10 2019
medline: 22 6 2021
entrez: 18 10 2019
Statut: ppublish

Résumé

Aromatase activity has commonly been associated with male infertility characterized by testicular dysfunction with low serum testosterone and/or testosterone to estradiol ratio. In this subset of patients, and particularly in those with hypogonadism, elevated levels of circulating estradiol may establish a negative feedback on the hypothalamic-pituitary-testicular axis by suppressing follicle-stimulating hormone (FSH) and luteinizing hormone (LH) production and impaired spermatogenesis. Hormonal manipulation via different agents such as selective estrogen modulators or aromatase inhibitors to increase endogenous testosterone production and improve spermatogenesis in the setting of infertility is an off-label option for treatment. We carried out a systematic review and meta-analysis of the literature of the past 30 years in order to evaluate the benefits of the use of aromatase inhibitors in the medical management of infertile/hypoandrogenic males. Overall, eight original articles were included and critically evaluated. Either steroidal (Testolactone) or nonsteroidal (Anastrozole and Letrozole) aromatase inhibitors were found to statistically improve all the evaluated hormonal and seminal outcomes with a safe tolerability profile. While the evidence is promising, future prospective randomized placebo-controlled multicenter trials are necessary to better define the efficacy of these medications.

Identifiants

pubmed: 31621654
pii: 269237
doi: 10.4103/aja.aja_101_19
pmc: PMC7406101
doi:

Substances chimiques

Aromatase Inhibitors 0
Anastrozole 2Z07MYW1AZ
Testosterone 3XMK78S47O
Estradiol 4TI98Z838E
Testolactone 6J9BLA949Q
Letrozole 7LKK855W8I

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

360-367

Déclaration de conflit d'intérêts

None

Références

Clin Biochem. 1981 Oct;14(5):243-51
pubmed: 6800671
Fertil Steril. 2012 Jul;98(1):48-51
pubmed: 22579129
Asian J Androl. 2013 Nov;15(6):806-11
pubmed: 24121976
Eur Urol. 2009 Nov;56(5):859-64
pubmed: 18657895
J Clin Endocrinol Metab. 2005 Oct;90(10):5717-22
pubmed: 16046582
J Urol. 2001 Mar;165(3):837-41
pubmed: 11176482
J Androl. 1989 May-Jun;10(3):240-7
pubmed: 2663800
Eur J Endocrinol. 2005 Feb;152(2):261-8
pubmed: 15745935
Stat Med. 2002 Feb 28;21(4):589-624
pubmed: 11836738
Hum Reprod. 2007 Jun;22(6):1506-12
pubmed: 17376819
Reprod Biol Endocrinol. 2011 Jun 21;9:93
pubmed: 21693046
J Urol. 2012 Mar;187(3):973-8
pubmed: 22264467
Fertil Steril. 2013 Mar 1;99(3):718-24
pubmed: 23219010
J Urol. 2002 Feb;167(2 Pt 1):624-9
pubmed: 11792932
Sex Med Rev. 2013 May;1(1):42-49
pubmed: 27784559
BJU Int. 2013 Mar;111(3 Pt B):E110-4
pubmed: 22958644
J Clin Oncol. 2002 Feb 1;20(3):751-7
pubmed: 11821457
Andrology. 2016 Jan;4(1):33-40
pubmed: 26588809
Ann Intern Med. 2011 Oct 18;155(8):529-36
pubmed: 22007046
J Clin Endocrinol Metab. 2006 Sep;91(9):3324-8
pubmed: 16787981
Fertil Steril. 2011 Feb;95(2):809-11
pubmed: 20934689
J Sex Med. 2015 Aug;12(8):1761-9
pubmed: 26176805
Fertil Steril. 2017 Mar;107(3):589-594
pubmed: 28069178
Clin Cancer Res. 1998 Sep;4(9):2089-93
pubmed: 9748124
J Endocrinol. 1996 Jan;148(1):1-9
pubmed: 8568455
J Clin Endocrinol Metab. 2008 Mar;93(3):784-91
pubmed: 18073301
Mol Cell Endocrinol. 2016 Jun 15;428:89-100
pubmed: 27004961
Ann N Y Acad Sci. 2005 Dec;1061:208-20
pubmed: 16467270
Fertil Steril. 2012 Dec;98(6):1359-62
pubmed: 23103016
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120

Auteurs

Francesco Del Giudice (F)

Department of Urology, Sapienza Rome University, Policlinico Umberto I, Rome 00161, Italy.

Gian Maria Busetto (GM)

Department of Urology, Sapienza Rome University, Policlinico Umberto I, Rome 00161, Italy.

Ettore De Berardinis (E)

Department of Urology, Sapienza Rome University, Policlinico Umberto I, Rome 00161, Italy.

Isabella Sperduti (I)

Biostatistical Unit, IRCCS, Regina Elena National Cancer Institute, Rome 00128, Italy.

Matteo Ferro (M)

Division of Urology, European Institute of Oncology, Milan 20141, Italy.

Martina Maggi (M)

Department of Urology, Sapienza Rome University, Policlinico Umberto I, Rome 00161, Italy.

Martin S Gross (MS)

Section of Urology, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03766, USA.

Alessandro Sciarra (A)

Department of Urology, Sapienza Rome University, Policlinico Umberto I, Rome 00161, Italy.

Michael L Eisenberg (ML)

Department of Urology, Stanford University, School of Medicine, Stanford, CA 94305, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH